|
Brussels, 19
July 2005
WHAT?
Nanotechnology and the health of the European Citizen in 2020
Special media programme on new developments in European nanotechnology
research and the future of healthcare on the occasion of EuroNanoForum
2005.
WHEN?
5-7 September 2005
WHERE?
EuroNanoForum 2005 Conference and Expo
The Edinburgh Exhibition and Conference Centre, Edinburgh, Scotland.
WHO?
Leading EU and international nanotechnology experts, nanotech industry
CEOs, senior policymakers from the EU, USA, China and Japan
EURONANOFORUM 2005: EUROPE’S FLAGSHIP
EVENT ON NANOTECHNOLOGY
Organized by the Institute of Nanotechnology, with
the support of the European Commission, EuroNanoForum 2005 is one
of the world’s most important Conference and Expo in the field
of nanotechnology research and industrial applications. This year,
this flagship European event will specifically focus on healthcare
application of nanotechnologies – and acknowledged area of
European strength and interest. Europe is at the forefront of scientific
advances in this field. In particular, EU researchers, developers
and scientists lead the way in the development of new procedures,
devices and applications in the field of healthcare. Heralding a
revolution in healthcare, nanotechnology research provides molecular-sized
solutions to some of the most pressing modern medical problems.
EU AT THE FOREFRONT OF NANOTECHNOLOGY –
AND HEALTH RESEARCH
Nanotechnology is a key area of European Research,
and one of the priorities of the 6th and 7th Framework programmes.
In the recently published European Nanotechnology Action Plan, the
EU has announced the ways in which it intends to keep Europe at
the forefront of the fast-moving field of nanotechnology in a safe
and responsible way.
Applications of nanotechnology – activities
at the level of atoms and molecules – are bringing a range
of benefits including more effective ways of delivering drugs to
treat diseases, faster computer processors and more efficient solar
cells. The Action Plan proposes measures to be taken at national
and EU level, including boosting funding for nanotechnology, developing
world-class competitive infrastructure, creating favourable conditions
for EU industry to turn research into useful products and services,
addressing public health, safety and environmental risks, promoting
inter-disciplinary education & training, and strengthening international
dialogue on key issues of mutual concerns.
THE CONFERENCE
EuroNanoForum2005 is the conference to attend in
2005 if you want:
- An understanding of advanced medical technologies
that have numerous applications in a variety of
industries including defence, textiles, ICT and many others.
- Insights into applications for the developing world
and ageing population.
- Indicators of new business opportunities and threats.
- To be at the forefront of the debate into ethics
and toxicology issues surrounding nanotechnology
The event will gather over 1500 participants
from all over the world, with over 90
leading speakers from 25 countries. During the Conference,
participants will be able to discover the latest developments in
tissue engineering, drug delivery and pharmaceutical development,
nano and congenital/ degenerative disease, nanoimaging, affordable
cures, implants and devices, new nano techniques and tools, risk
assessment and ethical responsibilities, and the impact of nanotechnology
on society.
THE MEDIA PROGRAMME
In addition to, and in parallel with, the general
Conference programme, in which journalists are invited to participate,
a dedicated press programme will be organised
on 5-7 September. The press programme will include :
- The first “town-hall meeting” and debate
with the public held in Europe on “Nanotechnology
– A Promising Revolution in Healthcare?”, on 5 September
18:00-20:00
- The presentation of 6 exciting EU research projects
on 6 September, and 7 Sept (morning)
- Meniscus regeneration - a novel material composed of the
patients' own cells on a fibrous matrix to reconstruct the
knee joint meniscus.
E. Tognana, Fidia Advanced Biopolymers, s.r.l. (I)
- Cornea engineering - three dimensional reconstruction of
the human cornea by tissue engineering
D.J.S. Hulmes, Institut de Biologie et Chimie des Protéines
CNRS 7 (F)
- Cellprom - cell programming by nanoscaled devices
Günter R. Fuhr, Institutsleiter Fraunhofer-Institut
fürBiomedizinische Technik (D)
- Nanosafe2: risk management strategies in nanotechnologies
M. Kayser, BASF Aktiengesellschaft (D)
- Nano2life: Network of Excellence supporting interdisciplinary
research into nanobiotechnology tools and techniques
Patrick Boisseau, CEA-Léti (F)
- Delivering cancer killing drugs through nanotechnologies
Andreas Jordan, CEO, MagForce Nanotechnologies GmbH (D)
- Interview opportunities and press points
with leading researchers and industry CEO, NGO representatives,
as well as senior policy makers from the EU, USA, China and Japan
- An exciting social programme with
gala dinner, whisky tasting, Scottish Ceilidh and civic reception
| NOTE
TO EDITORS
For additional information on this press briefing, please
contact:
Patrick Vittet-Philippe
Press and Information Officer
DG Research, European Commission
Tel: +32.2.296.9056 – Mobile: +32.477.274.663.
E-mail: patrick.vittet-philippe@ec.europa.eu
REGISTRATION: PLEASE RETURN THE ENCLOSED |
CONFIRMATION OF PARTICIPATION
EuroNanoForum 2005:
European nanotechnology research shapes the future of
healthcare
Edinburgh, Scotland, 5-7 September 2005
PLEASE E-MAIL to patrick.vittet-philippe@ec.europa.eu
OR FAX BACK to + 32 2 295 8220
[ ] Yes I will attend the EU press programme on
the occasion of EuroNanoForum 2005
Name:
Organsation:
E-Mail :
Tel and mobile tel :
Press/Professional card No :
[ ] No, I am unable to attend, but would like
to receive further information
|
For further information on EU Nanotechnology policy
and projects, see
http://cordis.europa.eu/nanotechnology/
For further information on EuroNanoForum 2005, please
visit:
http://www.euronanoforum2005.org
|